FDA Approved: JYLAMVO — Original Application (SHORLA ONCOLOGY INC.)

View source ↗

Summary

FDA approved JYLAMVO (methotrexate) under an Original Application from SHORLA ONCOLOGY INC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Choriocarcinoma
• Non-hodgkin Lymphoma
• Osteosarcoma
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• JYLAMVO (METHOTREXATE)

Snippet

ORIG AP for JYLAMVO (METHOTREXATE)